Effects of particle size on blood clearance and tissue uptake of lipid emulsions with different triglyceride compositions

Journal of Parenteral and Enteral Nutrition

Volumn 27, Issue 1, 2003, Pages 58-64

  Qi, Kemin ^b   Al Haideri, Maysoon ^b   Seo, Toru ^b   Carpentier, Yvon A ^a   Deckelbaum, Richard J ^b  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FISH OIL; HEPARIN; INTERMEDIATE DENSITY LIPOPROTEIN; LIPID EMULSION; LIPOPROTEIN LIPASE; LONG CHAIN TRIACYLGLYCEROL; MEDIUM CHAIN TRIACYLGLYCEROL; TRIACYLGLYCEROL; TRIDOCOSAHEXAENOIN; TRIOCTANOIN; TRIOLEIN; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATABOLISM; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG METABOLISM; DRUG UPTAKE; EXPERIMENTAL MODEL; FEMALE; HEART; LIPID METABOLISM; LIVER; MOUSE; NONHUMAN; PARTICLE SIZE; PLASMA CLEARANCE; PRIORITY JOURNAL;

ANIMALIA;

EID: 12244299198     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/014860710302700158     Document Type: Article

References (37)

1. Carpentier YA, Richelle M, Haumont D, et al: New developments in fat emulsions. Proc Nutr. Soc 49:375-380, 1990
2. Adolph M: Lipid emulsions in parenteral nutrition. Ann Nutr Metab 43:1-13, 1999
3. Collins-Gold L, Feichtinger N, Warnheim T: Are lipid emulsions the drug delivery solution? Modern Drug Discov 3:44-46, 2000
4. Carpentier YA: Intravascular metabolism of fat emulsions: The Arvid Wretlind lecture, ESPEN 1988. Clin Nutr 8:115-125, 1989
5. Olivecrona G, Olivecrona T: Clearance of artificial triacylglycerol particles. Curr Opin Clin Nutr Metab Care 1:143-151, 1998
6. Chan S, McCowen KC, Bistrian B: Medium-chain triglyceride and n-3 polyunsaturated fatty acid-containing emulsions in intravenous nutrition. Curr Opin Clin Nutr Metab Care 1:163-169, 1998
7. Rouis M, Dugi KA, Previato L, et al: Therapeutic response to medium-chain triglycerides and omega-3 fatty acids in a patient with the familiar chylomicronemia syndrome. Arterioscler Thromb Vasc Biol 17:1400-1406, 1997
8. Burr ML: Lessons from the story of n-3 fatty acids. Am J Clin Nutr 71:397S-398S, 2000
9. Horrocks LA, Yoe YK: Health benefits of docosahexaenoic acid (DHA). Pharmacol Res 40:211-225, 1999
10. Simopoulos AP: Essential fatty acids in health and chronic disease. Am J Clin Nutr 70:560S-569S, 1999
11. Yaqoob P: Lipids and the immune response. Curr Opin Clin Nutr Metab Care 1:153-161, 1998
12. Kang JX, Leaf A: Prevention of fetal cardiac arrhythmias by polyunsaturated fatty acids. Am J Clin Nutr 71:202-207, 2000
13. Rensen PCN, Herijgers N, Netscher MH, et al: Particle size determines the specificity of apolipoprotein E-containing triglyceride-rich emulsions for the LDL receptor versus hepatic remnant receptor in vivo. J Lipid Res 38:1070-1084, 1997
14. Lutz O, Meraihi Z, Mura JL, et al: Fat emulsion particle size: influence on the clearance rate and tissue lipolytic activity. Am J Clin Nutr 50:1370-1381, 1989
15. Martins IJ, Mortimer B-C, Miller J, et al: Effects of particle size and number on the plasma clearance of chylomicrons and remnants. J Lipid Res 37:2696-2705, 1996
16. Deckelbaum RJ, Hamilton JA, Moser A, et al: Medium-chain versus long-chain triacylglycerol emulsion hydrolysis by lipoprotein lipase and hepatic lipase: Implications for the mechanism of lipase action. Biochemistry 29:1136-1142, 1990
17. Hultin M, Mullertz A, Zundel MA, et al: Metabolism of emulsions containing medium- and long-chain triglycerides or interesterified triglycerides. J Lipid Res 35:1850-1860, 1994
18. Oliveira FLC, Rumsey SC, Schlotzer E, et al: Triglyceride hydrolysis of soy oil vs fish oil emulsions. JPEN 21:224-229, 1997
19. Blaner WS, Obunike JC, Kurlandsky SB, et al: Lipoprotein lipase hydrolysis of retinyl ester. Possible implications for retinoid uptake by cells. J Biol Chem 269:16559-16565, 1994
20. Schwiegelshohn B, Presley JF, Gorecki M, et al: Effects of apolipoprotein E on intracellular metabolism of model triglyceriderich particles are distinct from effects on cell particle uptake. J Biol Chem 270:1761-1769, 1995
21. Granot E, Schwiegelshohn B, Tabas I, et al: Effects of particle size on cell uptake of model triglyceride-rich particles with and without apoprotein E. Biochemistry 33:15190-15197, 1994
22. Al-Haideri M, Goldberg IJ, Galeano NF, et al: Heparan sulfate proteoglycan-mediated uptake of apolipoprotein E - triglyceriderich lipoprotein particles: A major pathway at physiological particle concentrations. Biochemistry 36:12766-12772, 1997
23. Bartlett GR: Phosphorus assay in column chromatography. J Biol Chem 234:466-468, 1959
24. Mims MP, Soma MR, Morrisett JD: Effect of particle size and temperature on the conformation and physiological behavior of apolipoprotein E bound to model lipoprotein particles. Biochemistry 29:6639-6647, 1990
25. van Bennekum AM, Kako Y, Weinstock PH: Lipoprotein lipase expression level influences tissue clearance of chylomicron retinyl ester. J Lipid Res 40:565-574, 1999
26. Mortimer BC, Beveridge DJ, Martin IJ, et al: Intracellular localization and metabolism of chylomicron remnants in the livers of low density lipoprotein receptor-deficient mice and apoE-deficient mice. J Biol Chem 270:28767-28776, 1995
27. Berman M: Kinetic analysis of turnover data. Prog Biochem Pharmacol 15:67-108, 1979
28. Qi K, Seo T, Al-Haideri M, et al: Omega-3 triglycerides modify blood clearance and tissue targeting pathways of lipid emulsions. Biochemistry 41:3119-3127, 2002
29. Hultin M, Carneheim C, Rosenquist K, et al: Intravenous lipid emulsions: Removal mechanisms as compared to chylomicrons. J Lipid Res 36:2174-2184, 1995
30. Hamilton JA, Vural JM, Carpentier YA, et al: Incorporation of medium-chain triacylglycerols into phospholipid bilayers: Effect of long chain triacylglycerols, cholesterol, and cholesteryl esters. J Lipid Res 37:773-782, 1996
31. Morley N, Kuksis A: Positional specificity of lipoprotein lipase. J Biol Chem 247:6389-6396, 1972
32. Hamberger L, Carpentier YA, Hansen I, et al: More efficient clearance of intravenous lipid emulsions containing medium chain triglyceride and fish oil triglyceride as compared to traditional long chain triglyceride lipid emulsions in vitro models and humans. Faseb J 15:23, 1996
33. Carpentier YA, Siderova VS, Richelle M, et al: Does the presence of fish oil in emulsion particles affect the elimination of MCT/LCT emulsion? Clin Nutr 15:2, 1996
34. Mulder M, Lombardi P, Jansen H, et al: Low density lipoprotein receptor internalizes low density and very low density lipoproteins that are bound to heparin sulfate proteoglycans via lipoprotein lipase. J Biol Chem 268:9369-9375, 1993
35. Rumsey SC, Obunike JC, Arad Y, et al: Lipoprotein lipase-mediated uptake and degradation of low density lipoproteins by fibroblasts and macrophages. J Clin Invest 90:1504-1512, 1992
36. Lookene A, Chevreuil O, Ostergard P, et al: Interaction of lipoprotein lipase with heparin fragments and with heparin sulfate: Stoichiometry, stabilization, and kinetics. Biochemistry 35:12155-12163, 1996
37. Wallinder L, Peterson J, Olivecrona T, et al: Hepatic and extra-hepatic uptake of intravenously injected lipoprotein lipase. Biochim Biophys Acta 795:513-524, 1984